Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectable DMAU for Male Contraception
NCT02927210Phase 1Completed
- Start
- Feb 2017
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dimethandrolone undecanoate in male contraception (8 arms). Primary endpoints: Incidence of treatment emergent adverse events, Changes from baseline in sexual function and 1 more. Started Feb 2017; status: completed.
02
Drugs
dimethandrolone undecanoate
03
Conditions
male contraception
Beyond the preview
Go deeper on NCT02927210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02927210.